Hexa Reports Market Research Reports and Insightful Company Profiles US Infectious Disease Testing Market Size, Share, Trends, Growth, Analysis and Outlook, Competitive Strategies And Forecasts, 2015-2019 About infectious disease testing Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of health care. Browse Detail Report With TOC @ http://www.hexareports.com/report/infectious-disease-testingmarket-in-the-us-2015-2019/details Manufacturers are developing diagnostic tests that can provide results in just a few minutes. For example, Alere developed Alere BinaxNOW Influenza A&B Card, which can detect influenza A & B in 15 minutes. Technavio's analysts forecast the infectious disease testing market in the US to grow at a CAGR of 5.81% over the period 2014-2019. Covered in this report Hexa Reports Market Research Reports and Insightful Company Profiles The report covers the current scenario and the growth prospects of the infectious disease testing market in the US for the period of 2015-2019. To calculate the market size, we consider the revenue generated from the sales of equipment and consumables from molecular diagnostics, POCT diagnostic devices, and immunodiagnostics, which are used to detect infectious diseases: The market is segmented based on technology: Molecular diagnostic test POCT Immunodiagnostic test The POCT for infectious disease is further segmented based on application: HIV Respiratory HAIs Sexual health Tropical diseases Hepatitis In addition, the market is segmented based on products: Equipment Consumables Technavio's report, Infectious Disease Testing Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report presents the vendor landscape and a corresponding detailed analysis of the five key vendors in the market. The vendor landscape focuses on vendors that provide access to new technologies. The report also outlines the challenges faced by vendors and the market at large, as well as the key trends emerging in the market. Key vendors Abbott Diagnostics Alere Beckman Coulter Diagnostics Roche Siemens Healthcare Market driver North America free trade agreement For a full, detailed list, view our report Market challenge Medical device excise tax law For a full, detailed list, view our report Hexa Reports Market Research Reports and Insightful Company Profiles Market trend Development of innovative diagnostics initiatives For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2019 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? Request A Sample copy of This Report @ http://www.hexareports.com/sample/83606 Table of Contents PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Market landscape Market overview PART 06: Infectious disease landscape in the US Reimbursement in US Clinical laboratory improvement amendments (CLIA) waiver from US Food and Drug Administration Five forces analysis PART 07: Market segmentation by technology Molecular diagnostic test POCT for infectious diseases Immunodiagnostic tests PART 08: Market segmentation by application PART 09: Market segmentation by product Equipment Consumables Hexa Reports Market Research Reports and Insightful Company Profiles PART 10: Market drivers Browse Full Report @ http://www.hexareports.com/report/infectious-disease-testing-market-in-the-us2015-2019/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in
Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide.
© Copyright 2024 Paperzz
